Stock Analiz

Tvardi Therapeutics, Inc. (TVRD) stock forecast and price target

Price $1.18 · data as of November 13, 2026

12-month price target

Average target$8.88
Upside / downside+652.1%
Analysts8
ConsensusBuy
Low $3.00Average $8.88High $14.00

Gold marker: average target · white marker: today’s price ($1.18)

Analyst ratings

Strong buy 2Buy 5Hold 1Sell 0Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.26+8.2%$0
Next fiscal year
ends December 31, 2027
$-2.03+10.2%$0
Next quarter
ends December 31, 2026
$-0.42+46.5%$0
Quarter after
ends March 31, 2027
$-0.35—$0

Consensus of the analysts covering Tvardi Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Tvardi Therapeutics stock price target?

The average 12-month target from 8 analysts is $8.88, 652.1% above the current price of $1.18 Targets range from $3.00 to $14.00.

Is Tvardi Therapeutics a buy according to analysts?

The consensus rating is “Buy” (2 strong buy, 5 buy, 1 hold, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Tvardi Therapeutics expected to earn?

Analysts expect EPS of $-2.26 for the fiscal year ending December 31, 2026 and $-2.03 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.